Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXHS2400035 | 达希替尼片 | XZP-3621 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-04-25 | view | ||||
CXHL2401216 | 达希替尼片 | XZP-3621 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-11-12 | Xuanzhu Biopharmaceutical Co Ltd | view | |||
CXHL2401215 | 达希替尼片 | XZP-3621 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-11-12 | Xuanzhu Biopharmaceutical Co Ltd | view | |||
CXHS2400036 | 达希替尼片 | XZP-3621 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-04-25 | view |